Although Fidelity Select Health Care’s 8.7% cumulative gain during the first half of 2021 was a solid absolute return, it significantly lagged the MSCI US IMI/Health Care 25-50 Index (its prospectus benchmark) and the S&P 1500 Health Care Index (the health Morningstar Category index), which gained 11.2% and 11.8%, respectively.
Will FSPHX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
The Process Pillar is our assessment of how sensible, clearly defined, and repeatable FSPHX’s performance objective and investment process is for both security selection and portfolio construction.
The People Pillar is our evaluation of the FSPHX management team’s experience and ability. We find that high-quality management teams deliver superior performance relative to their benchmarks and/or peers.
The Parent Pillar is our rating of FSPHX’s parent organization’s priorities and whether they’re in line with investors’ interests.